LEADER 02027nam  2200385   450 
001 9910688302503321
005 20230624085836.0
035   $a(CKB)5400000000043083
035   $a(NjHacI)995400000000043083
035   $a(EXLCZ)995400000000043083
100   $a20230624d2021      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aCardiovascular risk factors in pathology /$fAlaeddin Abukabda, Maria Suciu, Minodora Andor (editors)
210  1$aLondon :$cIntechOpen,$d[2021]
210  4$dİ2021
215   $a1 online resource
311   $a1-83881-951-7 
327   $a1. Endothelial Dysfunction and Disruption in Pulmonary Hypertension -- 2. Pathogenesis of Abdominal Aortic Aneurysm -- 3. The Importance of Autophagy and Proteostasis in Metabolic Cardiomyopathy -- 4. Familial Hypercholesterolemia: Three "under" (Understood, Underdiagnosed, and Undertreated) Disease -- 5. Statin Therapy in Children -- 6. Pharmacokinetic Aspects of Statins.
330   $aThis book provides a broad overview of the molecular mechanisms associated with relevant and significant cardiovascular conditions that continue to plague humanity. It also discusses potential and promising therapeutic avenues targeted at addressing these conditions. The overarching goal of this multifaceted work is to entice future and current members of the scientific community to direct their endeavors towards improving our current knowledge of cardiovascular disease conditions and curb their impact on our everyday lives.
606   $aCardiovascular system$xDiseases$xRisk factors
615  0$aCardiovascular system$xDiseases$xRisk factors.
676   $a616.1071
702   $aAndor$b Minodora
702   $aSuciu$b Maria
702   $aAbukabda$b Alaeddin
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910688302503321
996   $aCardiovascular Risk Factors in Pathology$92823521
997   $aUNINA